The new 18-month study, which will be conducted in partnership with the Trinity College Institute of Neuroscience in Dublin, Ireland, will help determine if the hypertension (high blood pressure) drug Nilvadipine could be useful in the treatment of Alzheimer's disease.
» Full text »
